all items  in current results   Refine your search within these categories: 1. Human Genes (group results) 1-acylglycerol-3-phosphate O-acyltransferases [HGNC:AGPAT] (11) 5-HT (serotonin) receptors [HGNC:HTR] (38) 7TM orphan receptors [HGNC:O7TM] (1) A-kinase anchor proteins [HGNC:AKAP] (32) Abhydrolase domain containing [HGNC:ABHD] (11) Acetylcholine receptors, nicotinic [HGNC:CHRN] (31) Acid-sensing (proton-gated) ion channels [HGNC:ASIC] (1) Actin related protein 2/3 complex subunits [HGNC:ARPC] (2) Acyl-CoA synthetase family [HGNC:ACS] (16) Acyl-CoA thioesterases [HGNC:ACOT] (8) more... 2. Interaction: Human Genes and Chemicals (group results) Affects (195) Decreases (206) Increases (207) 3. Bioactivity 4. Semantic Terms (group results) Entity [STY:T071] (46) Event [STY:T051] (1) A. Anatomy (group results) Body Regions [MESH:D001829] (117) Cardiovascular System [MESH:D002319] (140) Cells [MESH:D002477] (142) Digestive System [MESH:D004064] (80) Embryonic Structures [MESH:D004628] (24) Endocrine System [MESH:D004703] (50) Hemic and Immune Systems [MESH:D006424] (32) Integumentary System [MESH:D034582] (22) Musculoskeletal System [MESH:D009141] (127) Nervous System [MESH:D009420] (66) more... B. Organisms C01. Bacterial Infections and Mycoses (group results) Bacterial Infections [MESH:D001424] (196) Brain Abscess [MESH:D001922] (1) Infection [MESH:D007239] (214) Mycoses [MESH:D009181] (63) C02. Virus Diseases (group results) Virus Diseases [MESH:D014777] (210) C03. Parasitic Diseases (group results) Parasitic Diseases [MESH:D010272] (205) C04. Neoplasms (group results) Neoplasms [MESH:D009369] (232) C05. Musculoskeletal Diseases (group results) Musculoskeletal Diseases [MESH:D009140] (223) C06. Digestive System Diseases (group results) Digestive System Diseases [MESH:D004066] (231) C07. Stomatognathic Diseases (group results) Stomatognathic Diseases [MESH:D009057] (213) C08. Respiratory Tract Diseases (group results) Respiratory Tract Diseases [MESH:D012140] (231) Z. Exceptions (178) C09. Otorhinolaryngologic Diseases (group results) Otorhinolaryngologic Diseases [MESH:D010038] (231) C10. Nervous System Diseases (group results) Nervous System Diseases [MESH:D009422] (232) Z. Exceptions (231) C11. Eye Diseases (group results) Eye Diseases [MESH:D005128] (232) Z. Exceptions (63) C12. Male Urogenital Diseases (group results) Male Urogenital Diseases [MESH:D052801] (232) Z. Exceptions (2) C13. Female Urogenital Diseases and Pregnancy Complications: all > Female Urogenital Diseases [MESH:D052776] (group results) Genital Diseases, Female [MESH:D005831] (221) Urogenital Abnormalities [MESH:D014564] (232) Urogenital Neoplasms [MESH:D014565] (232) Urologic Diseases [MESH:D014570] (232) C14. Cardiovascular Diseases (group results) Cardiovascular Diseases [MESH:D002318] (231) Z. Exceptions (191) C15. Hemic and Lymphatic Diseases (group results) Hematologic Diseases [MESH:D006402] (211) Lymphatic Diseases [MESH:D008206] (209) Z. Exceptions (95) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: all > Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Eye Abnormalities [MESH:D005124] > Aniridia [MESH:D015783] > WAGR Syndrome [MESH:D017624] > Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome [MESH:C567292] C17. Skin and Connective Tissue Diseases (group results) Connective Tissue Diseases [MESH:D003240] (209) Skin Diseases [MESH:D012871] (225) C18. Nutritional and Metabolic Diseases (group results) Metabolic Diseases [MESH:D008659] (228) Nutrition Disorders [MESH:D009748] (232) Z. Exceptions (123) C19. Endocrine System Diseases (group results) Endocrine System Diseases [MESH:D004700] (232) Z. Exceptions (43) C20. Immune System Diseases (group results) Immune System Diseases [MESH:D007154] (223) Z. Exceptions (81) C21. Disorders of Environmental Origin (group results) Disorders of Environmental Origin [MESH:D007280] (2) C22. Animal Diseases (group results) Animal Diseases [MESH:D000820] (203) C23. Pathological Conditions, Signs and Symptoms (group results) Pathologic Processes [MESH:D010335] (231) Pathological Conditions, Anatomical [MESH:D020763] (222) Signs and Symptoms [MESH:D012816] (232) C24. Occupational Diseases (group results) Occupational Diseases [MESH:D009784] (198) Z. Exceptions (153) C25. Chemically-Induced Disorders (group results) Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (223) Poisoning [MESH:D011041] (224) Substance-Related Disorders [MESH:D019966] (231) C26. Wounds and Injuries (group results) Wounds and Injuries [MESH:D014947] (231) Z. Exceptions (185) D01. Inorganic Chemicals (group results) Arsenicals [MESH:D001152] (1) Cadmium Compounds [MESH:D019187] (1) Chlorine Compounds [MESH:D017606] (4) Electrolytes [MESH:D004573] (2) Elements [MESH:D004602] (11) Free Radicals [MESH:D005609] (2) Gases [MESH:D005740] (3) Mercury Compounds [MESH:D017669] (1) Metals [MESH:D008670] (8) Minerals [MESH:D008903] (1) more... D02. Organic Chemicals (group results) Organic Chemicals [MESH:D009930] (119) D03. Heterocyclic Compounds (group results) Heterocyclic Compounds [MESH:D006571] (80) D04. Polycyclic Compounds (group results) Polycyclic Compounds [MESH:D011083] (30) D05. Macromolecular Substances D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) Hormones [MESH:D006728] (5) D08. Enzymes and Coenzymes D09. Carbohydrates (group results) Carbohydrates [MESH:D002241] (9) D10. Lipids (group results) Lipids [MESH:D008055] (10) D12. Amino Acids, Peptides, and Proteins Amino Acids [MESH:D000596] (5) Peptides [MESH:D010455] (1) D13. Nucleic Acids, Nucleotides, and Nucleosides (group results) Nucleosides [MESH:D009705] (4) Nucleotides [MESH:D009711] (1) D20. Complex Mixtures (group results) Complex Mixtures [MESH:D045424] (5) D23. Biological Factors (group results) Biological Factors [MESH:D001685] (10) D25. Biomedical and Dental Materials D26. Pharmaceutical Preparations (group results) Drug Combinations [MESH:D004338] (1) Plant Extracts [MESH:D010936] (1) D27. Chemical Actions and Uses (group results) Pharmacologic Actions [MESH:D020228] (33) Specialty Uses of Chemicals [MESH:D020313] (8) Toxic Actions [MESH:D004786] (6) E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) Diagnosis [MESH:D003933] (232) F. Psychiatry and Psychology (group results) Behavior and Behavior Mechanisms [MESH:D001520] (140) Mental Disorders [MESH:D001523] (159) Psychological Phenomena and Processes [MESH:D011579] (10) G. Phenomena and Processes (group results) Chemical Phenomena [MESH:D055598] (8) Circulatory and Respiratory Physiological Phenomena [MESH:D002943] (78) Genetic Phenomena [MESH:D055614] (138) Musculoskeletal and Neural Physiological Phenomena [MESH:D055687] (25) Physiological Phenomena [MESH:D010829] (232) Reproductive and Urinary Physiological Phenomena [MESH:D012101] (6) I. Anthropology, Education, Sociology and Social Phenomena J. Technology, Industry, Agriculture (group results) Food and Beverages [MESH:D019602] (1) N. Health Care Recently Viewed Items Go to Item History

These terms define your current search. Click the × to remove a term. C13. Female Urogenital Diseases and Pregnancy Complications: Female Urogenital Diseases [MESH:D052776] × C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Eye Abnormalities [MESH:D005124] > Aniridia [MESH:D015783] > WAGR Syndrome [MESH:D017624] > Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome [MESH:C567292] × 232 items, grouped by D12. Amino Acids, Peptides, and Proteins (view ungrouped items) Amino Acids [MESH:D000596] (5)    MESH:C005177   benserazide, levodopa drug combination C005177               MESH:C079215   3,5-dihydroxyphenylglycine C079215               MESH:D000111   Acetylcysteine D000111               MESH:D005680   gamma-Aminobutyric Acid D005680               MESH:D008715   Methionine D008715               Peptides [MESH:D010455] (1)    MESH:C095170   4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid C095170